Medbox Inc (OTCMKTS:MDBX), a popular and renowned licensing, security and infrastructure specialist, partner to the cannabis market, and patented technology partner, said that under guidance of its new management team, the financial review has been completed. The review was announced some days ago.
Medbox submitted Form 8K with the SEC in which it stated that in connection with lately announced financial review, it intends to file a restated and amended Form 10 reflecting restated financial statements for the financial years ended December 31, 2012 and FY2013. It will also contain restated and amended forms 10Q for the 1Q2014, 2Q2014 and 3Q2014. The financial statements will be filed later this month. It will be done along with submission of all its public fillings. Medbox said that it expects to post results for FY2014 in March 2015.
The management view
The management of Medbox intends to conduct a conference call to highlight its financial performance, significant achievements and the strategic growth plans designed under its new leadership and executive team. Guy Marsala who is the President and CEO of Medbox since July 2014 stated that with the comprehensive financial assessment done, the management team wants to pay full attention to successfully executing the company’s business model and strategic plans. The company intends to provide its services to several clients who want to attain state license awards. The company will work with its ongoing support services.
Medbox Inc (OTCMKTS:MDBX) is a leading cultivation infrastructure, dispensary, and licensing specialist. It is better known as a patented technology provider and an integral part of the growing cannabis industry. It has extensive experience and expertise that it uses to support investors and entrepreneurs, who want to become a part of the cannabis sector. The company renders all kind of support services including licensing, permitting design, site selection, and full build-out.